自噬
巨噬细胞极化
下调和上调
槲皮素
炎症
药理学
巨噬细胞
伤口愈合
医学
体内
细胞凋亡
药品
癌症研究
药物输送
糖尿病
糖尿病足溃疡
化学
糖尿病足
PI3K/AKT/mTOR通路
炎症体
M2巨噬细胞
作者
Tianyi Ni,Qian Zhang,Yingying Wang,Min Yi,Liying Tu,Xiaowei Sun,Tinghong Xiang,Yiwen Gao,Zhechen Zhu,Wei Yan,Zhongqing Wei,Ming Wang
标识
DOI:10.1021/acsabm.6c00157
摘要
BACKGROUND: Diabetic foot ulcers (DFUs) represent a prevalent complication of diabetes mellitus, featuring elevated incidence, high amputation risk, and heavy economic medical burdens. Current clinical treatments for DFUs primarily focus on comprehensive care with limited efficacy. Quercetin, a flavonoid compound with antioxidant properties, has shown potential therapeutic effects in inflammatory-related diseases. OBJECTIVE: investigate the role of quercetin in activating Foxo3-induced macrophage autophagy and promoting M2 polarization in DFUs, and to evaluate the therapeutic efficacy of a quercetin co-crosslinked hydrogel for sustained drug delivery. METHODS: Animal models of DFUs were established to validate quercetin's ability to accelerate epithelialization and angiogenesis. RNA-seq screening revealed enhanced macrophage autophagy and upregulated Foxo3 expression under quercetin treatment. To optimize clinical applicability, a GelMA-Quercetin co-cross-linked hydrogel was developed for localized and sustained drug release. The in vivo therapeutic efficacy was evaluated by measuring wound closure, performing histological assessment, and analyzing macrophage polarization-related markers. RESULTS: Quercetin markedly improved diabetic wound repair by facilitating M2 macrophage polarization, promoting ROS elimination, and inhibiting NLRP3 inflammasome activation. The GelMA-Quercetin hydrogel demonstrated sustained drug release, achieving 80% cumulative release within 48 h, and markedly improved wound closure compared to saline and GelMA-only controls. Hydrogel-treated wounds exhibited reduced inflammation, increased angiogenesis, and accelerated epithelial regeneration. CONCLUSION: This study demonstrates that quercetin activates the Foxo3-autophagy axis to drive M2 macrophage polarization, thereby resolving chronic inflammation in DFUs. The GelMA-Quercetin hydrogel provides a clinically translatable strategy for localized therapy, combining sustained drug delivery with enhanced wound healing. These findings highlight quercetin's dual role as a molecular regulator and hydrogel-based therapeutic agent for DFUs.
科研通智能强力驱动
Strongly Powered by AbleSci AI